The prophylactic use of a Bakri balloon for women undergoing caesarean section for placenta praevia – a randomised controlled trial
Phase 4
Completed
- Conditions
- pregnancyplacenta praeviaReproductive Health and Childbirth - Childbirth and postnatal careReproductive Health and Childbirth - Other reproductive health and childbirth disorders
- Registration Number
- ACTRN12613000348752
- Lead Sponsor
- Michael Beckmann
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
All women with live singleton pregnancies =24+0 weeks undergoing caesarean section in the setting of a known placenta praevia (leading edge of placenta <20mm from the cervical os) will be suitable for inclusion in this study
Exclusion Criteria
Multiple pregnancy
Intrauterine Fetal Death
Suspected placenta accreta
Congenital abnormalities of the uterine cavity
Submucosal uterine fibroids >5cm
Women who give birth vaginally
Women aged <18 years
Inability to consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinician’s decision to undertake further intervention to control bleeding (eg increased rate/duration/concentration of Syntocinon infusion, Misoprostol, Ergometrine, B-lynch or other compression suture, Ergometrine, PGF2 alpha, ligation of uterine/ovarian/internal iliac arteries, hysterectomy). The use of any additional measures will be determined following a review of the intraoperative documentation by the research midwife and this information will be recorded on a dedicated data collection form. [Within the first 24 hours after birth.];Change in haemoglobin, This will be assessed by the research midwife by reviewing the routine pre-operative and post-operative full blood examination results. The information will be recorded on a dedication data collection form[The haemoglobin measured as part of routine pre-operative bloods (performed between 1hour and 72 hours pre-op) will be compared with post-operative haemoglobin (performed between 14h and 24 hours post-op)]
- Secondary Outcome Measures
Name Time Method